Fundz

Beyond Air, Inc. secures up to $30.1 million in a private placement offering, led by institutional healthcare investors, to support the commercial launch of its second-generation LungFit PH.

PUBLIC · XAIRJul 30, 2026

Amount Raised

$30.1 Million

Round Type

Post-IPO Equity

Garden CityBiotechnologyHealthcareHealth Care

Investors

Dan MoorheadRobert GoodmanInstitutional Healthcare Investors

Description

Beyond Air, Inc. has announced a securities purchase agreement for up to $30.1 million through a private placement offering. The financing, which provides the company with crucial capital, is led by institutional healthcare investors and includes participation from its directors and executive officers. This funding will aid in the planned commercial launch of the LungFit PH, subject to regulatory approval

Who to call at Beyond Air, and when

A new round usually means Beyond Air is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Beyond Air raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Beyond Air, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Beyond Air

Location

Garden City, New York, United States

About

Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. Beyond Air is currently advancing its other revolutionary LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria (NTM).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Beyond Air raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsKori-Ann T., Chief Executive Officer & Owner hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Beyond Air's next move

See what Strategic adds

Beyond Air raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.